Approval · Notice of Compliance 10384 · 2009

ZADITEN: Notice of Compliance 10384

Issued July 16, 2009

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 10384
Date: July 16, 2009
Company: Paladin Labs Inc
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Pediatric asthma prophylactic / Antiallergic agent

Products in this notice

Brand	DIN	Status today
ZADITEN	00577308	Marketed
ZADITEN	00600784	Cancelled Post Market

Medicinal ingredients

KETOTIFEN FUMARATE 1 MG per TAB
KETOTIFEN FUMARATE 1 MG per 5ML